company background image
2773

Chengdu Kanghong Pharmaceutical GroupSZSE:002773 Stock Report

Market Cap

CN¥17.0b

7D

-5.4%

1Y

-56.1%

Updated

20 Oct, 2021

Data

Company Financials +
2773 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends1/6

2773 Overview

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China.

Chengdu Kanghong Pharmaceutical Group Competitors

Novartis

SWX:NOVN

CHF171.5b

Regeneron Pharmaceuticals

NasdaqGS:REGN

US$57.4b

Alimera Sciences

NasdaqGM:ALIM

US$32.5m

Price History & Performance

Summary of all time highs, changes and price drops for Chengdu Kanghong Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥18.42
52 Week HighCN¥17.63
52 Week LowCN¥49.20
Beta-0.0048
1 Month Change-0.65%
3 Month Change-7.85%
1 Year Change-56.07%
3 Year Change-41.51%
5 Year Change-55.92%
Change since IPO83.17%

Recent News & Updates

Shareholder Returns

2773CN PharmaceuticalsCN Market
7D-5.4%-0.3%1.9%
1Y-56.1%-9.4%7.2%

Return vs Industry: 002773 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 002773 underperformed the CN Market which returned 7.2% over the past year.

Price Volatility

Is 2773's price volatile compared to industry and market?
2773 volatility
2773 Beta-0.0048
Industry Beta0.53
Market Beta1

Stable Share Price: 002773 is less volatile than 75% of CN stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 002773's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19963,882Xiao Kehttps://www.cnkh.com

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China. It offers ophthalmic systems, central nervous systems, digestive systems, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.

Chengdu Kanghong Pharmaceutical Group Fundamentals Summary

How do Chengdu Kanghong Pharmaceutical Group's earnings and revenue compare to its market cap?
2773 fundamental statistics
Market CapCN¥17.01b
Earnings (TTM)-CN¥183.94m
Revenue (TTM)CN¥3.80b

4.5x

P/S Ratio

-92.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2773 income statement (TTM)
RevenueCN¥3.80b
Cost of RevenueCN¥379.21m
Gross ProfitCN¥3.42b
ExpensesCN¥3.61b
Earnings-CN¥183.94m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.20
Gross Margin90.03%
Net Profit Margin-4.84%
Debt/Equity Ratio0%

How did 2773 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

-49%

Payout Ratio

Valuation

Is Chengdu Kanghong Pharmaceutical Group undervalued compared to its fair value and its price relative to the market?

2.78x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: 002773 (CN¥18.42) is trading above our estimate of fair value (CN¥9.05)

Significantly Below Fair Value: 002773 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 002773 is unprofitable, so we can't compare its PE Ratio to the CN Pharmaceuticals industry average.

PE vs Market: 002773 is unprofitable, so we can't compare its PE Ratio to the CN market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 002773's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 002773 is overvalued based on its PB Ratio (2.8x) compared to the CN Pharmaceuticals industry average (2.6x).


Future Growth

How is Chengdu Kanghong Pharmaceutical Group forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

73.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002773 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.3%).

Earnings vs Market: 002773 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 002773's is expected to become profitable in the next 3 years.

Revenue vs Market: 002773's revenue (17.6% per year) is forecast to grow slower than the CN market (18.4% per year).

High Growth Revenue: 002773's revenue (17.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 002773's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Chengdu Kanghong Pharmaceutical Group performed over the past 5 years?

-13.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 002773 is currently unprofitable.

Growing Profit Margin: 002773 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 002773 is unprofitable, and losses have increased over the past 5 years at a rate of 13.6% per year.

Accelerating Growth: Unable to compare 002773's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002773 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.6%).


Return on Equity

High ROE: 002773 has a negative Return on Equity (-3.02%), as it is currently unprofitable.


Financial Health

How is Chengdu Kanghong Pharmaceutical Group's financial position?


Financial Position Analysis

Short Term Liabilities: 002773's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥533.1M).

Long Term Liabilities: 002773's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥230.4M).


Debt to Equity History and Analysis

Debt Level: 002773 is debt free.

Reducing Debt: 002773 had no debt 5 years ago.

Debt Coverage: 002773 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 002773 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Chengdu Kanghong Pharmaceutical Group current dividend yield, its reliability and sustainability?

0.54%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 002773's dividend (0.54%) is higher than the bottom 25% of dividend payers in the CN market (0.42%).

High Dividend: 002773's dividend (0.54%) is low compared to the top 25% of dividend payers in the CN market (1.86%).


Stability and Growth of Payments

Stable Dividend: 002773 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 002773 has only been paying a dividend for 5 years, and since then payments have fallen.


Current Payout to Shareholders

Dividend Coverage: 002773 is paying a dividend but the company is unprofitable.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average board tenure


CEO

Xiao Ke (38 yo)

no data

Tenure

Mr. Xiao Ke serves as a General Manager and President of Chengdu Kanghong Pharmaceuticals Group Co., Ltd., and Director since June 21, 2010 and served as Vice President.


Board Members

Experienced Board: 002773's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.3%.


Top Shareholders

Company Information

Chengdu Kanghong Pharmaceutical Group Co., Ltd's employee growth, exchange listings and data sources


Key Information

  • Name: Chengdu Kanghong Pharmaceutical Group Co., Ltd
  • Ticker: 2773
  • Exchange: SZSE
  • Founded: 1996
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥17.010b
  • Shares outstanding: 919.46m
  • Website: https://www.cnkh.com

Number of Employees


Location

  • Chengdu Kanghong Pharmaceutical Group Co., Ltd
  • No.36, Shuxi Road
  • Jinniu District
  • Chengdu
  • Sichuan Province
  • 610036
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/20 09:03
End of Day Share Price2021/10/20 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.